1. Li, Xue, Yi, Han, Jin, Zheyu, Liu, Yanfang, Yu, Xiaofei. 2024. MCRS1 sensitizes T cell-dependent immunotherapy by augmenting MHC-I expression in solid tumors. In The Journal of experimental medicine, 221, . doi:10.1084/jem.20240959. https://pubmed.ncbi.nlm.nih.gov/39545935/
2. Keer, Stephanie, Cousin, Helene, Jourdeuil, Karyn, Alfandari, Dominique, Moody, Sally A. 2022. Mcrs1 is required for branchial arch and cranial cartilage development. In Developmental biology, 489, 62-75. doi:10.1016/j.ydbio.2022.06.002. https://pubmed.ncbi.nlm.nih.gov/35697116/
3. Liu, Minxia, Zhou, Kecheng, Huang, Yunchao, Cao, Yi. 2015. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway. In Journal of experimental & clinical cancer research : CR, 34, 121. doi:10.1186/s13046-015-0235-5. https://pubmed.ncbi.nlm.nih.gov/26467212/